Xpert Xpress SARS-CoV-2 cartridge now available from Stop TB Partnership’s Global Drug Facility
27 March 2020, Geneva, Switzerland – The Stop TB Partnership’s Global Drug Facility (GDF) has expanded its Diagnostics Catalog to include a new test for novel coronavirus SARS-CoV-2, the virus that causes COVID-19 disease. The Xpert Xpress SARS-CoV-2 test cartridges are now available at US$19.80 per cartridge from the manufacturer, Cepheid. For the full listing, see the GDF Diagnostics Catalog.
The Xpert Xpress SARS-CoV-2 cartridge received Emergency Use
Authorization (EUA) from the United States Food and Drug
Administration (FDA) on 21 March 2020. The cartridge can be used
on any of the currently available GeneXpert systems (GeneXpert
Systems running software version 4.7 or higher). Results are
available in 45 minutes. See the test’s
Instructions for Use
for more information.
The GDF is already engaging
with programmes and partners to determine the demand for new
COVID-19 tests and helping to determine the need for additional
machines to ensure TB testing continues while adding COVID-19
testing.
The GDF has been facilitating access to
GeneXpert systems and Xpert cartridges for the diagnosis of
tuberculosis (TB) and rifampicin-resistance TB for years,
delivering nearly 2.5 million TB cartridges to nearly 50
countries in 2019 alone and is thus well-positioned to support
programmes to access new tests for COVID-19.
For more
information about Xpert Xpress SARS-CoV-2 cartridge, please
contact GDF at [email protected].
About GDF
GDF is the largest
global provider of quality-assured TB diagnostics and laboratory
supplies to the public sector. The GDF Diagnostics Catalog
contains over 500 items, providing a full range of products to
meet the needs of TB laboratories from central to peripheral
levels. All countries can buy from GDF using any funding source,
including both donor and domestic resources.
Source:
Stop TB Partnership
